An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma

Francesca Reggiani, Elisabetta Sauta, Federica Torricelli, Eleonora Zanetti, Elena Tagliavini, Giacomo Santandrea, Giulia Gobbi, Giovanna Damia, Riccardo Bellazzi, Davide Ambrosetti, Alessia Ciarrocchi, Valentina Sancisi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number63
JournalMolecular Cancer
Volume20
Issue number1
DOIs
Publication statusPublished - Dec 2021

Keywords

  • CRISPR/Cas9 screening
  • EGLN1
  • HIF1A
  • KRAS
  • Lung cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Cite this